Neutron capture therapy principles and applications /

Por Sauerwein, Wolfgang A. G.
Publicado em c201

AT-07 A PHASE II STUDY OF LAPATINIB AND DOSE-DENSE TEMOZOLOMIDE (TMZ) FOR ADULTS WITH RECURRENT EPENDYMOMA: PATIENT REPORTED OUTCOMES (PRO) FROM A CERN CLINICAL TRIAL

Por Armstrong, Terri S., Vera-Bolanos, Elizabeth, Gilbert, Mark, Yuan, Ying, Wani, Khalida, Wu, Jimin, Omuro, Antonio, Lieberman, Frank, Robins, H. Ian, Gerstner, Elizabeth, Wu, Jing, Wen, Patrick, Mikkelsen, Tom, Aldape, Ken, Mendoza, Tito
Publicado em 2014

PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment

Por Cenciarelli, Carlo, Marei, Hany ES, Zonfrillo, Manuela, Pierimarchi, Pasquale, Paldino, Emanuela, Casalbore, Patrizia, Felsani, Armando, Vescovi, Angelo Luigi, Maira, Giulio, Mangiola, Annunziato
Publicado no Mol Cancer (2014)

Trends in End-of-Life Care in Pediatric Hematology, Oncology, and Stem Cell Transplant Patients

Por Brock, Katharine E., Steineck, Angela, Twist, Clare J.
Publicado no Pediatr Blood Cancer (2015)

SUN-616 A Rapidly Enlarging Neck Mass in a 59-Year-Old Woman

Por Nath, Priti, Hoang, Thanh, Bergeron, April, Glistercarlson, Babette, Shakir, Mohamed
Publicado no J Endocr Soc (2019)

Review of the neurological benefits of phytocannabinoids

Por Maroon, Joseph, Bost, Jeff
Publicado no Surg Neurol Int (2018)

Ustekinumab in chronic immune-mediated diseases: a review of long term safety and patient improvement

Por Toussirot, Éric, Michel, Fabrice, Béreau, Matthieu, Binda, Delphine
Publicado em 2013

GENE-16. Brd4-BOUND STRETCH/SUPER ENHANCER USAGE UNDERLIES SEXUAL DIMORPHISM IN GLIOBLASTOMA

Por Kfoury, Najla, Qi, Zongtai, Sankararaman, Sumithra, Wilkinson, Michael, Broestl, Lauren, Berrett, Kristopher, Gertz, Jason, Mitra, Robi, Rubin, Joshua
Publicado no Neuro Oncol (2017)

DIPG-11. ACTIVATION OF RAS SIGNALING AND DISTINCT MITOGEN-ACTIVATED PROTEIN KINASES (MAPKs) PROVIDES UNIQUE THERAPEUTIC VULNERABILITIES IN MUTANT HISTONE DIPG

Por Koncar, Robert, Stanton, Ann-Catherine, Dey, Brittany, Agrawal, Nishant, Wassell, Michelle, McCarl, Lauren, Locke, Abigail, Sanders, Lauren, Vaske, Olena Morozova, Kohanbash, Gary, Felker, James, James, C David, Hashizume, Rintaro, Broniscer, Alberto, Pollack, Ian, Agnihotri, Sameer
Publicado no Neuro Oncol (2019)

Venous Thromboembolism In Cancer Patients: “From Evidence to Care”

Por Mercedes Salgado, Elena Brozos-Vázquez, Begoña Campos, Paula González-Villarroel, María Eva Pérez, María Lidia Vázquez-Tuñas, David Arias
Publicado em 2022-05-01

How Nanotechnology and Biomedical Engineering Are Supporting the Identification of Predictive Biomarkers in Neuro-Oncology

Por Mario Ganau, Marco Paris, Nikolaos Syrmos, Laura Ganau, Gianfranco K.I. Ligarotti, Ali Moghaddamjou, Lara Prisco, Rossano Ambu, Salvatore Chibbaro
Publicado em 2018-02-01

Telomere Length and Risk of Glioma

Por Walcott, Farzana, Rajaraman, Preetha, Gadalla, Shahinaz M., Inskip, Peter D., Purdue, Mark P., Albanes, Demetrius, Orr, Esther, De Vivo, Immaculata, Savage, Sharon A.
Publicado em 2013

A phase Ib trial of the combination of the anti-angiogenic agent sunitinib and radiation therapy...

Por Wuthrick, Evan J., Kamrava, Mitchell, Curran, Walter J., Werner-Wasik, Maria, Camphausen, Kevin A., Hyslop, Terry, Axelrod, Rita, Andrews, David W., Glass, Jon, Machtay, Mitchell, Dicker, Adam P.
Publicado em 2011

Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastoma

Por Mandel, Jacob J, Yust-Katz, Shlomit, Patel, Akash J, Cachia, David, Liu, Diane, Park, Minjeong, Yuan, Ying, Kent, Thomas A, de Groot, John F
Publicado no Neuro Oncol (2018)

Potential for Nuclear Medicine Therapy for Glioblastoma Treatment

Por Bailly, Clément, Vidal, Aurelien, Bonnemaire, Coralie, Kraeber-Bodéré, Françoise, Chérel, Michel, Pallardy, Amandine, Rousseau, Caroline, Garcion, Emmanuel, Lacoeuille, Franck, Hindré, François, Valable, Samuel, Bernaudin, Myriam, Bodet-Milin, Caroline, Bourgeois, Mickaël
Publicado no Front Pharmacol (2019)

Safety Studies on Intrahepatic or Intratumoral Injection of Oncolytic Vesicular Stomatitis Virus Expressing Interferon-β in Rodents and Nonhuman Primates

Por Jenks, Nathan, Myers, Rae, Greiner, Suzanne M., Thompson, Jill, Mader, Emily K., Greenslade, Andrew, Griesmann, Guy E., Federspiel, Mark J., Rakela, Jorge, Borad, Mitesh J., Vile, Richard G., Barber, Glen N., Meier, Thomas R., Blanco, Michael C., Carlson, Stephanie K., Russell, Stephen J., Peng, Kah-Whye
Publicado em 2010

ACTR-66. BEVACIZUMAB THERAPY FOR THE TREATMENT OF ADULT GLIOBLASTOMA: SYSTEMATIC REVIEW & META-ANALYSIS

Por Kaka, Nagham, Hafazalla, Karim, Das, Sunit
Publicado no Neuro Oncol (2018)

DIPG-42. CAN WE CHANGE THE LANDSCAPE OF PEDIATRIC DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)? FIRST DEMONSTRATION OF CLINICAL AND RADIOGRAPHIC RESPONSE IN A PEDIATRIC H3-K27M MUTATED...

Por Hall, Matthew, Odia, Yazmin, Allen, Joshua, Tarapore, Rohinton, Khatib, Ziad, Maher, Ossama, Niazi, Toba, Daghistani, Doured, Schalop, Lee, Chi, Andrew, Oster, Wolfgang, Mehta, Minesh
Publicado no Neuro Oncol (2018)

Randomized Phase II Trial of Sorafenib with Temsirolimus or Tipifarnib in Untreated Metastatic Melanoma (S0438)

Por Margolin, Kim A., Moon, James, Flaherty, Lawrence E., Lao, Christopher D., Akerley, Wallace L., Othus, Megan, Sosman, Jeffrey A., Kirkwood, John M., Sondak, Vernon K.
Publicado em 2012

SV-BR-1-GM, a Clinically Effective GM-CSF-Secreting Breast Cancer Cell Line, Expresses an Immune Signature and Directly Activates CD4(+) T Lymphocytes

Por Lacher, Markus D., Bauer, Gerhard, Fury, Brian, Graeve, Sanne, Fledderman, Emily L., Petrie, Tye D., Coleal-Bergum, Dane P., Hackett, Tia, Perotti, Nicholas H., Kong, Ying Y., Kwok, William W., Wagner, Joseph P., Wiseman, Charles L., Williams, William V.
Publicado no Front Immunol (2018)